Anticoagulant use in atrial fibrillation and risk of dementia: review of contemporary knowledge

References

• Chinitz JS, Castellano JM, Kovacic JC, et al. Atrial fibrillation, stroke, and quality of life. Ann N Y Acad Sci. 2012;1254:140–150.
   PubMed Web of Science ®Google Scholar
• Colilla S, Crow A, Petkun W, et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112(8):1142–1147.
   PubMed Web of Science ®Google Scholar
• Lubitz SA, Moser C, Sullivan L, et al. Atrial fibrillation patterns and risks of subsequent stroke, heart failure, or death in the community. J Am Heart Assoc. 2013;2(5):e000126.
   PubMed Web of Science ®Google Scholar
• Savelieva I, Kakouros N, Kourliouros A, et al. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. Europace European Pacing, Arrhythmias, Cardiac Electrophysiology. 2011;13(3):308–328.
   Google Scholar
• Wakili R, Voigt N, Kaab S, et al. Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest. 2011;121(8):2955–2968.
   PubMed Web of Science ®Google Scholar
• Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263–272.
   PubMed Web of Science ®Google Scholar
• Prince M, Bryce R, Albanese E, et al. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimer’s Dementia. 2013;9(1):63–75.e2.
   PubMed Web of Science ®Google Scholar
• Chene G, Beiser A, Au R, et al. Gender and incidence of dementia in the Framingham Heart Study from mid-adult life. Alzheimer’s Dementia. 2015;11(3):310–320.
   PubMed Web of Science ®Google Scholar
• Hebert LE, Scherr PA, Beckett LA, et al. Age-specific incidence of Alzheimer’s disease in a community population. JAMA. 1995;273(17):1354–1359.
   PubMed Web of Science ®Google Scholar
• Tzourio C, Dufouil C, Ducimetiere P, et al. Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging. Neurology. 1999;53(9):1948–1952.
   PubMed Web of Science ®Google Scholar
• Mielke MM, Rosenberg PB, Tschanz J, et al. Vascular factors predict rate of progression in Alzheimer disease. Neurology. 2007;69(19):1850–1858.
   PubMed Web of Science ®Google Scholar
• Heneka MT, Carson MJ, El Khoury J, et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015;14(4):388–405.
   PubMed Web of Science ®Google Scholar
• Petersen RC, Stevens JC, Ganguli M, et al. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56(9):1133–1142.
   PubMed Web of Science ®Google Scholar
• Marzona I, Baviera M, Vannini T, et al. Risk of dementia and death in patients with atrial fibrillation: a competing risk analysis of a population-based cohort. Int J Cardiol. 2016;220:440–444.
   PubMed Web of Science ®Google Scholar
• Kling MA, Trojanowski JQ, Wolk DA, et al. Vascular disease and dementias: paradigm shifts to drive research in new directions. Alzheimer’s Dementia. 2013;9(1):76–92.
   PubMed Web of Science ®Google Scholar
• Brunner KJ, Bunch TJ, Mullin CM, et al. Clinical predictors of risk for atrial fibrillation: implications for diagnosis and monitoring. Mayo Clin Proc. 2014;89(11):1498–1505.
   PubMed Web of Science ®Google Scholar
• Cacciatore F, Abete P, Ferrara N, et al. Congestive heart failure and cognitive impairment in an older population. Osservatorio Geriatrico Campano Study Group. J Am Geriatr Soc. 1998;46(11):1343–1348.
   PubMed Web of Science ®Google Scholar
• Jozwiak A, Guzik P, Mathew A, et al. Association of atrial fibrillation and focal neurologic deficits with impaired cognitive function in hospitalized patients >or=65 years of age. Am J Cardiol. 2006;98(9):1238–1241.
   PubMed Web of Science ®Google Scholar
• Bilato C, Corti MC, Baggio G, et al. Prevalence, functional impact, and mortality of atrial fibrillation in an older Italian population (from the Pro.V.A. study). Am J Cardiol. 2009;104(8):1092–1097.
   PubMed Web of Science ®Google Scholar
• Crandall MA, Horne BD, Day JD, et al. Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors. Pacing Clin Electrophysiol. 2009;32(8):981–986.
   PubMed Web of Science ®Google Scholar
• Bangen KJ, Nation DA, Delano-Wood L, et al. Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer’s disease. Alzheimer’s & Dementia. 2015;11(4):394–403.e1.
   PubMed Web of Science ®Google Scholar
• Marinigh R, Lip GY, Fiotti N, et al. Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis. J Am Coll Cardiol. 2010;56(11):827–837.
   PubMed Web of Science ®Google Scholar
• Ott A, Breteler MMB, de Bruyne MC, et al. Atrial fibrillation and dementia in a population-based study: the rotterdam study. Stroke. 1997;28(2):316–321.
   PubMed Web of Science ®Google Scholar
• Bunch TJ, Weiss JP, Crandall BG, et al. Atrial fibrillation is independently associated with senile, vascular, and Alzheimer’s dementia. Heart Rhythm. 2010;7(4):433–437.
   PubMed Web of Science ®Google Scholar
• Proietti M, Recchia A, Riva E, et al. Relationship between atrial fibrillation and cognitive decline in individuals aged 80 and older: a narrative review. Eur J Intern Med. 2017.
   Web of Science ®Google Scholar
• Stewart S, Hart CL, Hole DJ, et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113(5):359–364.
   PubMed Web of Science ®Google Scholar
• Miyasaka Y, Barnes ME, Bailey KR, et al. Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. J Am Coll Cardiol. 2007;49(9):986–992.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Wolf PA, D’Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98(10):946–952.
   PubMed Web of Science ®Google Scholar
• Tilvis RS, Kahonen-Vare MH, Jolkkonen J, et al. Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol A Biol Sci Med Sci. 2004;59(3):268–274.
   PubMed Web of Science ®Google Scholar
• Elias MF, Sullivan LM, Elias PK, et al. Atrial fibrillation is associated with lower cognitive performance in the Framingham offspring men. J Stroke Cerebrovasc Dis. 2006;15(5):214–222.
   PubMedGoogle Scholar
• Forti P, Maioli F, Pisacane N, et al. Atrial fibrillation and risk of dementia in non-demented elderly subjects with and without mild cognitive impairment (MCI). Arch Gerontol Geriatr. 2007;44(Supplement):155–165.
   PubMedGoogle Scholar
• Peters R, Poulter R, Beckett N, et al. Cardiovascular and biochemical risk factors for incident dementia in the hypertension in the very elderly trial. J Hypertens. 2009;27(10):2055–2062.
   PubMed Web of Science ®Google Scholar
• Dublin S, Anderson ML, Haneuse SJ, et al. Atrial fibrillation and risk of dementia: a prospective cohort study. J Am Geriatr Soc. 2011;59(8):1369–1375.
   PubMed Web of Science ®Google Scholar
• Marzona I, O’Donnell M, Teo K, et al. Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies. CMAJ Canadian Medical Association Journal = journal de l’Association medicale canadienne. 2012;184(6):E329–36.
   PubMed Web of Science ®Google Scholar
• de Bruijn RF, Heeringa J, Wolters FJ, et al. Association between atrial fibrillation and dementia in the general population. JAMA Neurol. 2015;72(11):1288–1294.
   PubMed Web of Science ®Google Scholar
• Kalantarian S, Ruskin JN. Atrial fibrillation and cognitive decline: phenomenon or epiphenomenon? Cardiol Clin. 2016;34(2):279–285.
   PubMed Web of Science ®Google Scholar
• Bunch TJ, Crandall BG, Weiss JP, et al. Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22(8):839–845.
   PubMed Web of Science ®Google Scholar
• Peters R. The prevention of dementia. Int J Geriatr Psychiatry. 2009;24(5):452–458.
   PubMed Web of Science ®Google Scholar
• Moschetti K, Cummings PL, Sorvillo F, et al. Burden of Alzheimer’s disease-related mortality in the United States, 1999–2008. J Am Geriatr Soc. 2012;60(8):1509–1514.
   PubMed Web of Science ®Google Scholar
• Lip GY, Lane DA. Stroke prevention in atrial fibrillation: a systematic review. Jama. 2015;313(19):1950–1962.
   PubMed Web of Science ®Google Scholar
• Lip GY, Tse HF, Lane DA. Atrial fibrillation. Lancet. 2012;379(9816):648–661.
   PubMed Web of Science ®Google Scholar
• Charidimou A, Shakeshaft C, Werring DJ. Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk. Front Neurol. 2012;3:133.
   PubMedGoogle Scholar
• Jacobs V, Woller SC, Stevens S, et al. Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia. Heart Rhythm. 2014;188:93–98.
   Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Revista espanola de cardiologia (English Ed). 2017;70(1):50.
   PubMed Web of Science ®Google Scholar
• Jacobs V, Woller SC, Stevens SM, et al. Percent time with a supratherapeutic INR in atrial fibrillation patients also using an antiplatelet agent is associated with long-term risk of dementia. J Cardiovasc Electrophysiol. 2015;26:1180–1186.
   Web of Science ®Google Scholar
• Kwok CS, Loke YK, Hale R, et al. Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis. Neurology. 2011;76(10):914–922.
   PubMed Web of Science ®Google Scholar
• Kalantarian S, Stern TA, Mansour M, et al. Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med. 2013;158(5 Pt 1):338–346.
   PubMed Web of Science ®Google Scholar
• Jacobs V, May HT, Bair TL, et al. Long-term population-based cerebral ischemic event and cognitive outcomes of direct oral anticoagulants compared with warfarin among long-term anticoagulated patients for atrial fibrillation. Am J Cardiol. 2016;118(2):210–214.
   PubMed Web of Science ®Google Scholar
• Graves KG, May HT, Jacobs V, et al. Atrial fibrillation incrementally increases dementia risk across all CHADS2 and CHA2DS2VASc strata in patients receiving long-term warfarin. Am Heart J. 2017;188:93–98.
   PubMed Web of Science ®Google Scholar
• Inzitari D, Di Carlo A, Pracucci G, et al. Incidence and determinants of poststroke dementia as defined by an informant interview method in a hospital-based stroke registry. Stroke. 1998;29(10):2087–2093.
   PubMed Web of Science ®Google Scholar
• Tang WK, Chan SS, Chiu HF, et al. Frequency and clinical determinants of poststroke cognitive impairment in nondemented stroke patients. J Geriatr Psychiatry Neurol. 2006;19(2):65–71.
   PubMed Web of Science ®Google Scholar
• Mizrahi EH, Waitzman A, Arad M, et al. Atrial fibrillation predicts cognitive impairment in patients with ischemic stroke. Am J Alzheimers Dis Other Demen. 2011;26(8):623–626.
   PubMed Web of Science ®Google Scholar
• Anselmino M, Scarsoglio S, Saglietto A, et al. Transient cerebral hypoperfusion and hypertensive events during atrial fibrillation: a plausible mechanism for cognitive impairment. Sci Rep. 2016;6:28635.
   PubMed Web of Science ®Google Scholar
• Hui DS, Morley JE, Mikolajczak PC, et al. Atrial fibrillation: a major risk factor for cognitive decline. Am Heart J. 2015;169(4):448–456.
   PubMed Web of Science ®Google Scholar
• Kanmanthareddy A, Vallakati A, Sridhar A, et al. The impact of atrial fibrillation and its treatment on dementia. Curr Cardiol Rep. 2014;16(8):519.
   PubMed Web of Science ®Google Scholar
• Mazurek M, Shantsila E, Lane DA, et al. Guideline-adherent antithrombotic treatment improves outcomes in patients with atrial fibrillation. Mayo Clinic Proceedings. 2017;92(8):1203–1213.
   PubMed Web of Science ®Google Scholar
• Tavassoli N, Perrin A, Berard E, et al. Factors associated with undertreatment of atrial fibrillation in geriatric outpatients with Alzheimer disease. Am J Cardiovasc Drugs. 2013;13(6):425–433.
   PubMed Web of Science ®Google Scholar
• Wilke T, Groth A, Pfannkuche M, et al. Real life anticoagulation treatment of patients with atrial fibrillation in Germany: extent and causes of anticoagulant under-use. J Thromb Thrombolysis. 2015;40(1):97–107.
   PubMed Web of Science ®Google Scholar
• Andrade JG, Macle L, Nattel S, et al. Contemporary atrial fibrillation management: a comparison of the current AHA/ACC/HRS, CCS, and ESC guidelines. Can J Cardiol. 2017;33(8):965–976.
   PubMed Web of Science ®Google Scholar
• Maes F, Dalleur O, Henrard S, et al. Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation? Clin Interv Aging. 2014;9:1091–1099.
   PubMed Web of Science ®Google Scholar
• Puccio D, Novo G, Baiamonte V, et al. Atrial fibrillation and mild cognitive impairment: what correlation? Minerva Cardioangiol. 2009;57(2):143–150.
   PubMedGoogle Scholar
• Barber M, Tait RC, Scott J, et al. Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation. J Thromb Haemost. 2004;2(11):1873–1878.
   PubMed Web of Science ®Google Scholar
• Mavaddat N, Roalfe A, Fletcher K, et al. Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham atrial fibrillation treatment of the aged study). Stroke. 2014;45(5):1381–1386.
   PubMed Web of Science ®Google Scholar
• Flaker GC, Pogue J, Yusuf S, et al. Cognitive function and anticoagulation control in patients with atrial fibrillation. Circ Cardiovasc Quality Outcomes. 2010;3(3):277–283.
   PubMed Web of Science ®Google Scholar
• O’Donnell MJ, Eikelboom JW, Yusuf S, et al. Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study. Am Heart J. 2016;178:145–150.
   PubMed Web of Science ®Google Scholar
• Lubitz SA, Yin X, Lin HJ, et al. Genetic risk prediction of atrial fibrillation. Circulation. 2017;135(14):1311–1320.
   PubMed Web of Science ®Google Scholar
• Hall JL. Questions, behavior, and responsibility in precision medicine. Circulation. 2017;135(14):1321–1324.
   PubMed Web of Science ®Google Scholar